mitomycin has been researched along with Glioma in 14 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of chemotherapy drug Mitomycin C (MMC) in combination with recombinant adeno-associated virus II (rAAV2) in cancer therapy was investigated, and the mechanism of MMC affecting rAAV2's bioactivity was also studied." | 5.39 | Effect and mechanism of Mitomycin C combined with recombinant adeno-associated virus type II against glioma. ( Deng, Y; Han, C; Lei, R; Ma, H; Qing, H; Rao, L; Wang, H; Xiang, J; Yang, Z; Zhang, L; Zhang, Y, 2013) |
| "Cytotoxic T lymphocytes (CTL) against autologous malignant brain tumor were generated in peripheral blood lymphoid cells (PBL) prepared from a patient with a malignant brain tumor by stimulation of the cultured PBL for 7 days with attenuated crossreactive malignant melanoma (MM2) cells pretreated with mitomycin C." | 3.69 | Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation. ( Fujimoto, S; Kurisaka, M; Maeda, N; Mori, K; Saitoh, S, 1997) |
| "The effect of chemotherapy drug Mitomycin C (MMC) in combination with recombinant adeno-associated virus II (rAAV2) in cancer therapy was investigated, and the mechanism of MMC affecting rAAV2's bioactivity was also studied." | 1.39 | Effect and mechanism of Mitomycin C combined with recombinant adeno-associated virus type II against glioma. ( Deng, Y; Han, C; Lei, R; Ma, H; Qing, H; Rao, L; Wang, H; Xiang, J; Yang, Z; Zhang, L; Zhang, Y, 2013) |
| "Metronidazole, 1." | 1.27 | Feasibility study of combining metronidazole with chemotherapy. ( Bélanger, R; Crook, AF; Heringer, R; Hopkins, HS; Hugenholtz, H; Maroun, JA; Richard, MT; Stewart, DJ; Yan, RC; Young, V, 1983) |
| " Both dosage and releasing time can be adjusted." | 1.27 | [Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites]. ( Himuro, H; Inoue, N; Kaetsu, I; Kitamura, K; Kubo, O; Sakairi, M; Tajika, T; Tajika, Y; Tohyama, T; Yoshida, M, 1986) |
| "In those with metastatic brain tumors, the median survival time was 280 days, 1-year survival rate 43." | 1.27 | [Clinical application of a sustained release anticancer pellet]. ( Aoyama, I; Handa, H; Hashi, K; Kamijyo, Y; Mori, K; Oda, Y; Okumura, T; Tokuriki, Y; Yamashita, J, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kokoshka, JM | 1 |
| Ireland, CM | 1 |
| Barrows, LR | 1 |
| Ma, H | 1 |
| Zhang, Y | 1 |
| Wang, H | 1 |
| Han, C | 1 |
| Lei, R | 1 |
| Zhang, L | 1 |
| Yang, Z | 1 |
| Rao, L | 1 |
| Qing, H | 1 |
| Xiang, J | 1 |
| Deng, Y | 1 |
| Li, H | 1 |
| Liu, T | 1 |
| Chen, X | 2 |
| Xie, L | 1 |
| Chen, Y | 1 |
| Douglass, T | 1 |
| Jeffes, EW | 1 |
| Xu, Q | 1 |
| Williams, CC | 1 |
| Arpajirakul, N | 1 |
| Delgado, C | 1 |
| Kleinman, M | 1 |
| Sanchez, R | 1 |
| Dan, Q | 1 |
| Kim, RC | 1 |
| Wepsic, HT | 1 |
| Jadus, MR | 1 |
| Yuan, S | 1 |
| Wang, Y | 1 |
| Jiang, S | 1 |
| Yang, Y | 1 |
| Song, Y | 1 |
| Tu, C | 1 |
| Stewart, DJ | 1 |
| Maroun, JA | 1 |
| Young, V | 1 |
| Crook, AF | 1 |
| Hopkins, HS | 1 |
| Yan, RC | 1 |
| Richard, MT | 1 |
| Hugenholtz, H | 1 |
| Bélanger, R | 1 |
| Heringer, R | 1 |
| Saitoh, S | 1 |
| Kurisaka, M | 1 |
| Mori, K | 2 |
| Maeda, N | 1 |
| Fujimoto, S | 1 |
| Nitta, T | 1 |
| Nikkhah, G | 1 |
| Tonn, JC | 1 |
| Hoffmann, O | 1 |
| Kraemer, HP | 1 |
| Darling, JL | 1 |
| Schachenmayr, W | 1 |
| Schönmayr, R | 1 |
| Nakamura, O | 1 |
| Matsutani, M | 1 |
| Nomura, K | 1 |
| Takakura, K | 1 |
| Kawakami, K | 1 |
| Kawamoto, K | 1 |
| Oka, N | 1 |
| Kawamura, Y | 1 |
| Matsumura, H | 1 |
| Ito, T | 1 |
| Ohyama, A | 1 |
| Kubo, O | 1 |
| Himuro, H | 1 |
| Inoue, N | 1 |
| Tajika, Y | 1 |
| Tajika, T | 1 |
| Tohyama, T | 1 |
| Sakairi, M | 1 |
| Yoshida, M | 1 |
| Kaetsu, I | 1 |
| Kitamura, K | 1 |
| Ito, H | 1 |
| Hasegawa, T | 1 |
| Shoin, K | 1 |
| Hwang, WZ | 1 |
| Hayashi, M | 1 |
| Yamamoto, S | 1 |
| Miyazaki, I | 1 |
| Oda, Y | 1 |
| Kamijyo, Y | 1 |
| Okumura, T | 1 |
| Tokuriki, Y | 1 |
| Yamashita, J | 1 |
| Handa, H | 1 |
| Aoyama, I | 1 |
| Hashi, K | 1 |
1 review available for mitomycin and Glioma
| Article | Year |
|---|---|
[A history and prospect of adoptive immunotherapy against malignant glioma--past, now and future].
Topics: Brain Neoplasms; Glioma; Humans; Immunotherapy, Adoptive; Immunotoxins; Interleukin-2; Killer Cells, | 1992 |
13 other studies available for mitomycin and Glioma
| Article | Year |
|---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Forma | 1996 |
Effect and mechanism of Mitomycin C combined with recombinant adeno-associated virus type II against glioma.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Dependovirus; Genetic Therapy | 2013 |
A rare case of primary congenital glaucoma in combination with neurofibromatosis 1: a case report.
Topics: Alkylating Agents; Brain Neoplasms; Combined Modality Therapy; Glioma; Humans; Hydrophthalmos; Infan | 2015 |
Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9
Topics: Animals; Antibodies; Brain Neoplasms; Cell Death; Chemokines, CXC; Chemotactic Factors; Female; Free | 2002 |
[Study on chemosensitivity assay in vitro in the peripheral blood lymphocyte and the tumor cells].
Topics: Antineoplastic Agents; Brain Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Glioma; Human | 2000 |
Feasibility study of combining metronidazole with chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Sq | 1983 |
Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.
Topics: Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Autoant | 1997 |
The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Survival; Colony-Forming Units Assay; Color | 1992 |
[Drug sensitivity test against malignant gliomas].
Topics: Animals; Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Screening Assays, Antitumor; Glioma; Hu | 1990 |
[Flow cytometric studies of brain tumors--5: New sensitivity test of antineoplastic agents for brain tumors and its clinical application].
Topics: Animals; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Cell Cycle; Cell Survival; Colony-Formin | 1986 |
[Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites].
Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Implants; Dysge | 1986 |
[Necrotomy of brain stem glioma and local administration of anticancer agents].
Topics: Administration, Topical; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; B | 1985 |
[Clinical application of a sustained release anticancer pellet].
Topics: Antineoplastic Agents; Brain Neoplasms; Delayed-Action Preparations; Drug Administration Schedule; F | 1985 |